Sumit Sarkar
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Researcher
Also affiliated: Tufts University (2002–2004); Boston Children's Hospital (2009); Tufts Medical Center (2001–2005); United States Food and Drug Administration (2011–2026); Rashtrasant Tukadoji Maharaj Nagpur University (1999–2001); Harvard University (2009); Indiana University School of Medicine (2005–2017); Indiana University – Purdue University Indianapolis (2005–2017); Maulana Abul Kalam Azad Institute of Asian Studies (2024); Maulana Abul Kalam Azad University of Technology, West Bengal (2024)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Sumit Sarkar's research focuses on neurological disorders, particularly Alzheimer's disease, and its underlying mechanisms. His work has investigated the role of metals in Alzheimer's disease progression and explored methods for in vivo demonstration of amyloid plaques in rat models. Sarkar has also examined the role of astrocytes in the glymphatic network, a critical system for waste clearance in the brain. His research extends to understanding sex-related neuropathology and cognitive deficits in mouse models of Alzheimer's disease, and he has explored the connection between Alzheimer's disease and type 3 diabetes, with a specific interest in African American populations.
Additionally, Sarkar's research has addressed broader neurotoxicity, including quantitative analysis of rat brain toxicity following exposure to trimethyltin. He has also contributed to the development and characterization of methods for localizing plaques and tangles in both rodent and human brain tissue, employing techniques such as Congo Red labeling and modified K114 staining. His work is supported by collaborations with researchers at the National Center for Toxicological Research, including James Raymick, Serguei Liachenko, Merle G. Paule, and E. Ellen Jones. Sarkar is a highly cited researcher with an h-index of 35 and over 111 publications.
Metrics
- h-index: 35
- Publications: 111
- Citations: 4,366
Selected Publications
-
A new method for visualizing cerebrovascular vessels (2026)
-
Potential link of high fat diet and mRNA expression of Alzheimer's disease-related genes in the enteric mucosa of a rat model of Alzheimer's disease (2025)
-
Developing non-invasive molecular markers for early risk assessment of Alzheimer's disease (2025)
-
The incorporation of MALDI mass spectrometry imaging in studies to identify markers of toxicity following in utero opioid exposures in mouse fetuses (2024)
-
Evaluation and Characterization of Modified K114 Method to LocalizePlaques in Rodent and Plaques and Tangles in Human Brain Tissue (2024)
-
In vivo mapping of rat brain partial white matter content using hexachlorophene-induced neurotoxicity model (2024)
-
A novel humanized Tau‐FAD mice represent a robust model for studying AD‐related dysfunction (2023)
-
The role of astrocytes in the glymphatic network: a narrative review (2023)
-
Combining tissue clearing and Fluoro-Jade C labeling for neurotoxicity assessments (2023)
-
Assessment of sex-related neuropathology and cognitive deficits in the Tg-SwDI mouse model of Alzheimer’s disease (2022)
-
Development of early biomarkers of Alzheimer's disease: A precision medicine perspective (2022)
-
Evaluation of Styrylbenzene analog- FSB and its affinity to bind parenchymal plaques and tangles in patients of Alzheimer’s disease (2022)
-
Circulating biomarkers of neurotoxicity: Proteomics approach reveals fluidic endpoints of central nervous system toxicity in a rodent model of neurotoxicity (2021)
-
Role of metals in Alzheimer’s disease (2021)
-
Alzheimer’s disease: a step closer to understanding type 3 diabetes in African Americans (2021)
Collaboration Network
Top Collaborators
- In vivo demonstration of Congo Red labeled amyloid plaques via perfusion in the Alzheimer disease rat model
- Assessment of sex-related neuropathology and cognitive deficits in the Tg-SwDI mouse model of Alzheimer’s disease
- Global Neurotoxicity: Quantitative Analysis of Rat Brain Toxicity Following Exposure to Trimethyltin
- Evaluation and Characterization of Modified K114 Method to LocalizePlaques in Rodent and Plaques and Tangles in Human Brain Tissue
- Evaluation of Styrylbenzene analog- FSB and its affinity to bind parenchymal plaques and tangles in patients of Alzheimer’s disease
Showing 5 of 7 shared publications
- Role of metals in Alzheimer’s disease
- In vivo demonstration of Congo Red labeled amyloid plaques via perfusion in the Alzheimer disease rat model
- Evaluation and Characterization of Modified K114 Method to LocalizePlaques in Rodent and Plaques and Tangles in Human Brain Tissue
- Evaluation of Styrylbenzene analog- FSB and its affinity to bind parenchymal plaques and tangles in patients of Alzheimer’s disease
- Potential link of high fat diet and mRNA expression of Alzheimer's disease-related genes in the enteric mucosa of a rat model of Alzheimer's disease
Showing 5 of 6 shared publications
- In vivo demonstration of Congo Red labeled amyloid plaques via perfusion in the Alzheimer disease rat model
- Assessment of sex-related neuropathology and cognitive deficits in the Tg-SwDI mouse model of Alzheimer’s disease
- Evaluation and Characterization of Modified K114 Method to LocalizePlaques in Rodent and Plaques and Tangles in Human Brain Tissue
- Evaluation of Styrylbenzene analog- FSB and its affinity to bind parenchymal plaques and tangles in patients of Alzheimer’s disease
- Role of metals in Alzheimer’s disease
- The role of astrocytes in the glymphatic network: a narrative review
- Evaluation of Styrylbenzene analog- FSB and its affinity to bind parenchymal plaques and tangles in patients of Alzheimer’s disease
- Development of early biomarkers of Alzheimer's disease: A precision medicine perspective
- Global Neurotoxicity: Quantitative Analysis of Rat Brain Toxicity Following Exposure to Trimethyltin
- In vivo mapping of rat brain partial white matter content using hexachlorophene-induced neurotoxicity model
- Circulating biomarkers of neurotoxicity: Proteomics approach reveals fluidic endpoints of central nervous system toxicity in a rodent model of neurotoxicity
- Global Neurotoxicity: Quantitative Analysis of Rat Brain Toxicity Following Exposure to Trimethyltin
- Circulating biomarkers of neurotoxicity: Proteomics approach reveals fluidic endpoints of central nervous system toxicity in a rodent model of neurotoxicity
- Alzheimer’s disease: a step closer to understanding type 3 diabetes in African Americans
- Circulating biomarkers of neurotoxicity: Proteomics approach reveals fluidic endpoints of central nervous system toxicity in a rodent model of neurotoxicity
- Development of early biomarkers of Alzheimer's disease: A precision medicine perspective
- A novel humanized Tau‐FAD mice represent a robust model for studying AD‐related dysfunction
- Global Neurotoxicity: Quantitative Analysis of Rat Brain Toxicity Following Exposure to Trimethyltin
- Global Neurotoxicity: Quantitative Analysis of Rat Brain Toxicity Following Exposure to Trimethyltin
- Alzheimer’s disease: a step closer to understanding type 3 diabetes in African Americans
- Alzheimer’s disease: a step closer to understanding type 3 diabetes in African Americans
- Alzheimer’s disease: a step closer to understanding type 3 diabetes in African Americans
- Circulating biomarkers of neurotoxicity: Proteomics approach reveals fluidic endpoints of central nervous system toxicity in a rodent model of neurotoxicity
- Circulating biomarkers of neurotoxicity: Proteomics approach reveals fluidic endpoints of central nervous system toxicity in a rodent model of neurotoxicity
Similar Researchers
Based on overlapping research topics